ID   51FSDNC18
AC   CVCL_RH71
SY   DOXTOX3 hiPSC
DR   SKIP; SKIP001183
DR   Wikidata; Q54603710
RX   PubMed=27089514;
CC   Donor information: Established from a breast cancer patient who received doxorubicin and experienced cardiotoxicity.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
RX   PubMed=27089514; DOI=10.1038/nm.4087; PMCID=PMC5086256;
RA   Burridge, Paul Weisley
RA   Li, Yong Fuga
RA   Matsa, Elena
RA   Wu, Hao-Di
RA   Ong, Sang-Ging
RA   Sharma, Arun
RA   Holmstrom, Alexandra
RA   Chang, Alex C.
RA   Coronado, Michael J.
RA   Ebert, Antje D.
RA   Knowles, Joshua Wiley
RA   Telli, Melinda L.
RA   Witteles, Ronald M.
RA   Blau, Helen Margaret
RA   Bernstein, Daniel
RA   Altman, Russ Biagio
RA   Wu, Joseph C.
RT   "Human induced pluripotent stem cell-derived cardiomyocytes
RT   recapitulate the predilection of breast cancer patients to
RT   doxorubicin-induced cardiotoxicity.";
RL   Nat. Med. 22:547-556(2016).
//